• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cutera Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

By: Cutera, Inc. via Business Wire
October 06, 2023 at 17:00 PM EDT

Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that on October 3, 2023 the Compensation Committee of Cutera’s Board of Directors approved the grant of inducement awards to Brent Hauser, who joined Cutera on October 2, 2023, as the President, International. The inducement awards consisted of restricted stock units (RSUs) settleable in 27,358 shares of common stock, and two grants of performance stock units (PSUs) settleable in 54,716 shares of common stock and 25,000 shares of common stock, respectively.

The RSUs were granted on October 3, 2023. A quantity of 25% shall vest on October 2, 2024, and 1/12 of the RSUs shall vest each quarter thereafter, subject to Mr. Hauser continuing as an employee.

The PSU grants were granted on October 3, 2023. Regarding the PSU grant of 54,716 shares of common stock, the performance-based vesting schedule and targets will be determined by Cutera’s Board of Directors or Compensation Committee. The PSU grant of 25,000 shares of common stock has a single performance criteria of the 30-calendar day trailing average of Cutera’s closing common stock price exceeding $20.00 within four years of the grant date.

Each inducement award is subject to the terms of the Cutera, Inc. 2023 Inducement Equity Incentive Plan and related forms of agreements and were granted as inducements material to these employees to enter into employment with Cutera in accordance with Nasdaq Listing Rule 5635(c)(4).

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231006071746/en/

Contacts

Greg Barker

VP, Corporate FP&A and Investor Relations

415-657-5500

IR@cutera.com

More News

View More
Analysts Flock to Upgrade DELL After Big AI-Server Guidance Boost
Today 16:14 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers DELL MSFT
Amazon Is on the Cusp of Becoming a Grocery Disruptor
Today 16:03 EDT
Via MarketBeat
Tickers ACI AMZN COST KR WMT
Pure Storage Hits New High: AI’s Under-the-Radar Powerhouse
Today 15:33 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers CRWD IT MSFT PSTG
MP Materials' New Role as a Strategic U.S. Asset
Today 14:22 EDT
Via MarketBeat
Topics Economy Government
Tickers AAPL MP
3 Healthcare Companies Insiders Are Buying
Today 14:09 EDT
Via MarketBeat
Topics Initial Public Offering
Tickers CAMP LLY SI
Recent Quotes
View More
Symbol Price Change (%)
GOOG  246.19
+1.55 (0.63%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap